日期 影响因子
日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:
–

Comparative evaluation of stability, efficacy, and sterility in five repackaged intravitreal anti-vascular endothelial growth factor medications

五种重新包装的玻璃体内抗血管内皮生长因子药物的稳定性、疗效和无菌性比较评价

期刊:Scientific Reports
影响因子:3.9
doi:10.1038/s41598-026-39102-5
Thunwiriya, Panintorn; Phetruen, Tanaporn; Chaiwijit, Phaewa; Tonawannakorn, Chaiyawat; Dekham, Kanokwan; Thadtapong, Nalumon; Chaturongakul, Soraya; Charoensawan, Varodom; Chanarat, Sittinan; Pakotiprapha, Danaya; Hanutsaha, Prut
心血管
发表日期：2026
文献求助 收藏

Perception of online learning, knowledge assessment, and clinical skills among third-year ophthalmology residents studying during the COVID-19 pandemic in Thailand

泰国新冠疫情期间三年级眼科住院医师对在线学习、知识评估和临床技能的看法

期刊:Scientific Reports
影响因子:3.9
doi:10.1038/s41598-026-35674-4
Chuenkongkaew, Wanicha; Chalermpong, Jimethat; Kiddee, Weerawat; Hanutsaha, Prut; Manassakorn, Anita; Suwan-Apichon, Olan; Vongkittirux, Sakchai; Choontanom, Raveewan; Phamonvaechavan, Pittaya; Kasemsup, Tharnsook; Kunavisarut, Paradee; Somboonthanakij, Sudawadee; Silpa-Archa, Sukhum; Pruksakorn, Vannakorn; Tsutsumi, Wantanee Dangboon; Chirapapaisan, Niphon
微生物学
新冠
发表日期：2026
文献求助 收藏

Cost-Utility Analysis of Deep Learning and Trained Human Graders for Diabetic Retinopathy Screening in a Nationwide Program

全国性糖尿病视网膜病变筛查项目中深度学习与训练有素的人工阅片员的成本效用分析

期刊:Ophthalmology and Therapy
影响因子:3.2
doi:10.1007/s40123-023-00688-y
Srisubat, Attasit; Kittrongsiri, Kankamon; Sangroongruangsri, Sermsiri; Khemvaranan, Chalida; Shreibati, Jacqueline Baras; Ching, Jack; Hernandez, John; Tiwari, Richa; Hersch, Fred; Liu, Yun; Hanutsaha, Prut; Ruamviboonsuk, Varis; Turongkaravee, Saowalak; Raman, Rajiv; Ruamviboonsuk, Paisan
糖尿病视网膜病变
视网膜病变
神经科学
代谢
Human
糖尿病
发表日期：2023
文献求助 收藏

Clinical Correlation of Retinal Fluid Fluctuation Represented by Fluctuation Index in Wet Age-Related Macular Degeneration: TOWER Study Report 2

湿性年龄相关性黄斑变性中视网膜液波动（以波动指数表示）的临床相关性：TOWER 研究报告 2

期刊:Translational Vision Science & Technology
影响因子:2.6
doi:10.1167/tvst.12.10.2
Chantarasorn, Yodpong; Ruamviboonsuk, Paisan; Thoongsuwan, Somanus; Vongkulsiri, Sritatath; Kungwanpongpun, Pavinee; Hanutsaha, Prut
发表日期：2023
文献求助 收藏

Treatment Outcome of Wet Age-Related Macular Degeneration Management in Thailand: A Retrospective Real-World Study (TOWER Study)

泰国湿性年龄相关性黄斑变性治疗结果：一项回顾性真实世界研究（TOWER 研究）

期刊:Ophthalmology and Therapy
影响因子:3.2
doi:10.1007/s40123-022-00471-5
Thoongsuwan, Somanus; Hanutsaha, Prut; Chantarasorn, Yodpong; Ruamviboonsuk, Paisan; Vongkulsiri, Sritatath; Kungwanpongpun, Pavinee
发表日期：2022
文献求助 收藏

A real-world study of effectiveness of intravitreal bevacizumab and ranibizumab injection for treating retinal diseases in Thailand

泰国一项关于玻璃体内注射贝伐珠单抗和雷珠单抗治疗视网膜疾病疗效的真实世界研究

期刊:BMC Ophthalmology
影响因子:1.7
doi:10.1186/s12886-019-1086-1
Kumluang, Suthasinee; Ingsrisawang, Lily; Sangroongruangsri, Sermsiri; Chaikledkaew, Usa; Ratanapakorn, Tanapat; Ruamviboonsuk, Paisan; Taweebanjongsin, Wongsiri; Choovuthayakorn, Janejit; Thoongsuwan, Somanus; Hanutsaha, Prut; Kulvichit, Kittisak; Ratanapojnard, Thitiporn; Wongsawad, Warapat; Leelahavarong, Pattara; Teerawattananon, Yot
发表日期：2019
文献求助 收藏

Real-World Safety of Intravitreal Bevacizumab and Ranibizumab Treatments for Retinal Diseases in Thailand: A Prospective Observational Study

泰国视网膜疾病患者玻璃体内注射贝伐珠单抗和雷珠单抗治疗的真实世界安全性：一项前瞻性观察研究

期刊:Clinical Drug Investigation
影响因子:2.7
doi:10.1007/s40261-018-0678-5
Sangroongruangsri, Sermsiri; Chaikledkaew, Usa; Kumluang, Suthasinee; Wu, Olivia; Geue, Claudia; Ratanapakorn, Tanapat; Leelahavarong, Pattara; Ingsrisawang, Lily; Ruamviboonsuk, Paisan; Taweebanjongsin, Wongsiri; Choovuthayakorn, Janejit; Singalavanija, Apichart; Hanutsaha, Prut; Kulvichit, Kittisak; Ratanapojnard, Thitiporn; Wongsawad, Warapat; Teerawattananon, Yot
发表日期：2018
文献求助 收藏